Synthesis and evaluation of novel biaryl oxazolidinones effective against gram-positive bacterial infections

被引：0

作者：

Bhawsar, Satish ^{[1
]}

Shaikh, Mohammad ^{[1
]}

Joshi, Sanjeev ^{[1
]}

Mishra, Amit ^{[1
]}

Pavase, Laxmikant ^{[1
]}

Chavan, Vijay ^{[1
]}

Kale, Amol ^{[1
]}

Kayastha, Abhijeet K. ^{[1
]}

Yeole, Ravindra ^{[1
]}

Bhagwat, Sachin ^{[1
]}

Patel, Mahesh ^{[1
]}

机构：

[1] MIDC, Wockhardt Res Ctr, D-4, Aurangabad 431006, Maharashtra, India

来源：

MEDICINAL CHEMISTRY RESEARCH | 2024年 / 33卷 / 10期

关键词：

Biaryl oxazolidinones; antibiotics; gram-positive; MRSA; WCK; 3999; 4603;

D O I：

10.1007/s00044-024-03287-z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Oxazolidinones are synthetic antibiotic class of compounds characterized by chemical structure, cyclic carbamate with 'S' configuration of substituent at C-5 position. The synthesis of oxazolidinones has gained increasing interest due to their unique mechanism of action that assures high antibiotic efficiency and low susceptibility to resistance mechanisms. Biaryl oxazolidinones are second-generation oxazolidinone (e.g. Tedizolid) having potency against multidrug-resistant (MDR) gram-positive pathogens including MRSA, VRE, penicillin-resistant S. pneumoniae and linezolid-resistant strains. The current manuscript covers structure activity based synthesis of 21 oxazolidinone analogs prepared through various chemical modifications. These novel biaryl oxazolidinones are prepared with the objective to increase spectrum of activity against multidrug-resistant Gram-positive bacteria. [GRAPHICS] .

引用

页码：1887 / 1896

页数：10

共 50 条

[21] A Novel Derivative of Thioridazine Shows Low Toxicity and Efficient Activity against Gram-Positive Pathogens
Jorgensen, Nadia S.
Saaby, Lasse
Andersson, Anne M.
Kromann, Sofie
Sheikhsamani, Ehsan
Permin, Anders
Ronco, Troels
Svenningsen, Soren W.
Christensen, Jorn B.
Olsen, Rikke H.
ANTIBIOTICS-BASEL, 2020, 9 (06): : 1 - 11
[22] Surveillance of gram-positive cocci infections and drug resistance
Li, G.
Hou, S.
Li, Y.
Liu, S.
Teng, D.
Hou, D.
CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (04) : 90 - 93
[23] Streptogramins for the treatment of infections caused by Gram-positive pathogens
Reissier, Sophie
Cattoir, Vincent
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (05) : 587 - 599
[24] Daptomycin treatment in Gram-positive vascular graft infections
de las Revillas, Francisco Arnaiz
Fernandez-Sampedro, Marta
Maria Arnaiz-Garcia, Ana
Gutierrez-Cuadra, Manuel
Arminanzas, Carlos
Pulitani, Ivana
Ponton, Alejandro
Tascon, Valentin
Garcia, Ivan
Carmen Farinas, Maria
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 68 : 69 - 73
[25] Antibiotics for treatment of resistant gram-positive coccal infections
Hossam Al-Tatari
Nahed Abdel-Haq
Pimpanada Chearskul
Basim Asmar
The Indian Journal of Pediatrics, 2006, 73 (4) : 323 - 334
[26] Optimizing outcomes in patients with serious Gram-positive infections
Miro, J. M.
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 1 - 4
[27] Oritavancin as sequential therapy for Gram-positive bloodstream infections
Williams Monier Texidor
Matthew A. Miller
Kyle C. Molina
Martin Krsak
Barbara Calvert
Caitlin Hart
Marie Storer
Douglas N. Fish
BMC Infectious Diseases, 24
[28] Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria
Lee, Hee-Yeol
An, Kyung-Mi
Jung, Juyoung
Koo, Je-Min
Kim, Jeong-Geun
Yoon, Jong-Min
Lee, Myong-Jae
Jang, HyeonSoo
Lee, Hong-Sub
Park, Soobong
Kang, Jae-Hoon
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (13) : 3148 - 3152
[29] Dalbavancin: A new option for the treatment of gram-positive infections
Lin, SW
Carver, PL
DePestel, DD
ANNALS OF PHARMACOTHERAPY, 2006, 40 (03) : 449 - 460
[30] Oritavancin as sequential therapy for Gram-positive bloodstream infections
Texidor, Williams Monier
Miller, Matthew A.
Molina, Kyle C.
Krsak, Martin
Calvert, Barbara
Hart, Caitlin
Storer, Marie
Fish, Douglas N.
BMC INFECTIOUS DISEASES, 2024, 24 (01)

← 1 2 3 4 5 →